Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
29 January 2020
Vitamin С for health protection for the children of Sopharma
Financial News
5 April 2021
Sales revenues for March 2021
2 April 2021
Notification on the adoption of a decision for amendments to the Articles of Association of the Company
26 March 2021
Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC)
Financial Highlights 31 December, 2020
1,439,879
BGN '000 Revenue
90,607
BGN '000 EBITDA
44,000
BGN '000 Revenue from operating profit
19,977
BGN '000 Net profit for the year
0.199
BGN Earnings per share

Next events
5 May 2021
Publication of the Annual Consolidated Audit Report for 2020
5 May 2021
Individual financial statements for Q1 of 2021

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A